Climb Bio Stock News & Updates
[WKN: A3CWUQ | Symbol: CLYM]
Climb Bio: How a modified antibody could change the market for kidney diseases
Climb Bio (CLYM) focuses on its lead product CLYM116 aimed at the addressable market for IgA Nephropathy...
Climb Bio: Promising Pipeline Meets Well-Filled Coffers
Climb Bio is a clinical-stage biotech company specializing in the development of novel antibody therapies...
Climb Bio: Promising Pipeline Meets Well-Filled Coffers
Climb Bio is a clinical-stage biotech company that specializes in developing novel antibody therapies...
- ‹
- 1
- ›